Cargando…
Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial
OBJECTIVE: Implantable cardiac defibrillators (ICDs) for primary prevention (PP) of sudden cardiac arrest (SCA) are well-established but underutilized globally. The Improve SCA study has identified a cohort of patients called 1.5 primary prevention (1.5PP) based on PP patients with the presence of c...
Autores principales: | Holbrook, Reece, Higuera, Lucas, Wherry, Kael, Phay, Dave, Hsieh, Yu-Cheng, Lin, Kuo-Hung, Liu, Yen-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676667/ https://www.ncbi.nlm.nih.gov/pubmed/33211698 http://dx.doi.org/10.1371/journal.pone.0241697 |
Ejemplares similares
-
Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022) -
Implantable cardioverter-defibrillators /
Publicado: (1994) -
Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021) -
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)